O9A.412
Sexual abuse complicating pregnancy, second trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Sexual abuse during pregnancy is a serious concern that can have profound effects on both the expectant mother and the developing fetus. When such abuse occurs during the second trimester—the period between 13 and 26 weeks of pregnancy—it complicates the pregnancy and requires careful medical attention. Healthcare professionals aim to identify, support, and treat women experiencing this traumatic situation to ensure their safety and well-being, along with that of their unborn child.
Causes & Symptoms
Clinical Causes: Underlying abusive relationships where coercion or violence is present Patterns of domestic violence that escalate during pregnancy Psychological or emotional factors that lead to power imbalance Situations where the abuser seeks control over the pregnant woman Pre-existing abusive behaviors that continue or increase during pregnancy
Key Symptoms: Physical signs such as bruises, injuries, or trauma that may be evident or hidden Psychological symptoms including anxiety, depression, fear, and withdrawal Pregnancy complications like preterm labor or bleeding, possibly linked to trauma Reluctance to discuss personal safety or feelings of shame and guilt Unexplained medical issues that prompt concern among healthcare providers
Diagnostic & Treatment
Diagnosis Path: Diagnosing sexual abuse during pregnancy involves a sensitive and confidential approach, often including the following steps:
Treatment Protocols: Addressing sexual abuse complications during pregnancy involves a multidisciplinary and empathetic strategy designed to support the woman’s safety, health, and emotional well-being:
Clinical Advice & FAQs
Billing Guidance
Is O9A.412 a billable ICD-10 code?
Yes, O9A.412 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O9A.412?
Clinical documentation must specify the nature of Sexual abuse complicating pregnancy, second trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference